The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Uterine sarcoma patients who underwent morcellation: Who are they? Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA- NOGGO RU1).
 
Eva Roser
No Relationships to Disclose
 
Rebecca Mirbach
No Relationships to Disclose
 
Peter Reichardt
Honoraria - Boehringer Ingelheim (Inst); Clinigen Group (Inst); Deciphera (Inst); PharmaMar (Inst)
Consulting or Advisory Role - Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Mundipharma (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst)
Research Funding - Novartis (Inst)
 
Dario Zocholl
No Relationships to Disclose
 
Maximillian Klar
Honoraria - AstraZeneca; Roche
Expert Testimony - AstraZeneca; KLS Martin; Roche
Travel, Accommodations, Expenses - Intuitive Surgical
 
Philipp Harter
Honoraria - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Lilly; MSD Oncology; Roche; Sotio; Stryker; Zai Lab
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Merck; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Roche (Inst)
 
Stefan Kommoss
Honoraria - AstraZeneca; GlaxoSmithKline; MSD; Myriad Pharmaceuticals; Roche
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD; Myriad Pharmaceuticals; Roche
 
Uwe Andreas Ulrich
No Relationships to Disclose
 
Alexander Mustea
Honoraria - GlaxoSmithKline; Novartis; Roche
Consulting or Advisory Role - GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - GlaxoSmithKline; PharmaMar; PlanTEC
 
Pauline Wimberger
Honoraria - Amgen; AstraZeneca; Clovis Oncology GmbH; Eisai; GlaxoSmithKline; Lilly; MSD Oncology; Novartis/Pfizer; Pfizer; Roche Pharma AG; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology GmbH; Eisai Germany; Eisai Germany; GlaxoSmithKline; Lilly; MSD Oncology; Novartis; Pfizer; PharmaMar; Roche Pharma AG; Tesaro; Teva
Travel, Accommodations, Expenses - Roche Pharma AG
 
Michael Weigel
Consulting or Advisory Role - AstraZeneca; Lilly O.; Novartis; Roche
Speakers' Bureau - AstraZeneca; Lilly O.; Novartis; Roche
Travel, Accommodations, Expenses - Lilly O.
 
Matthias Frank
No Relationships to Disclose
 
Barbara Schmalfeldt
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD Oncology; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD Oncology; Roche Pharma AG
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD; Roche
 
Lars Ch. Hanker
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Pfizer; Roche
 
Anne Flörcken
No Relationships to Disclose
 
Tjadina Arndt
No Relationships to Disclose
 
Klaus Pietzner
Honoraria - AstraZeneca; GlaxoSmithKline/Tesaro; Merck Sharp & Dohme; MSD; Roche
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline/Tesaro; Merck Sharp & Dohme; MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline/Tesaro; Roche
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - Alkermes; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Ingress Health; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Riemser; Roche; Sobi; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro